Finder may earn compensation from partners, but editorial opinions are our own. Advertiser Disclosure

How to buy CytoDyn stock | $1.34

Learn how to easily invest in CytoDyn stock.

CytoDyn Inc (CYDY) is a leading biotechnology business based in the US. It opened the day at $1.34 after a previous close of $1.35. During the day the price has varied from a low of $1.29 to a high of $1.36. The latest price was $1.34 (25 minute delay). CytoDyn is listed on the OTCQB and employs 24 staff. All prices are listed in US Dollars.

How to buy shares in CytoDyn

  1. Compare share trading platforms.Use our comparison table to help you find a platform that fits you.
  2. Open your brokerage account. Complete an application with your details.
  3. Confirm your payment details. Fund your account.
  4. Research the stock. Find the stock by name or ticker symbol – CYDY – and research it before deciding if it's a good investment for you.
  5. Purchase now or later. Buy your desired number of shares with a market order or use a limit order to delay your purchase until the stock reaches a desired price.
  6. Check in on your investment. Optimize your portfolio by tracking your stock.

CytoDyn stock price (OTCQB: CYDY)

Use our graph to track the performance of CYDY stocks over time.

CytoDyn shares at a glance

Information last updated 2021-08-20.
Open$1.34
High$1.36
Low$1.29
Close$1.34
Previous close$1.35
Change $-0.01
Change % -0.7407%
Volume 1,048,107
Information last updated 2021-10-16.
52-week range$1.25 - $7.40
50-day moving average $1.73
200-day moving average $2.02
Wall St. target price$4.00
PE ratio N/A
Dividend yield N/A (0%)
Earnings per share (TTM) $-0.26

Buy CytoDyn shares from these brokerages

Compare special offers, low fees and a wide range of types of investments among top trading platforms.
Name Product Asset types Option trade fee Annual fee Signup bonus
Robinhood
Robinhood
Stocks, Options, ETFs, Cryptocurrency
$0
0%
Free stock (chosen randomly with a value anywhere between $2.50 and $200)
Sign up using the "go to site" link
Make unlimited commission-free trades in stocks, funds, and options with Robinhood Financial.
J.P. Morgan Self-Directed Investing
Stocks, Bonds, Options, Mutual funds, ETFs
$0 + $0.65/contract
0%
N/A
INVESTMENT AND INSURANCE PRODUCTS ARE: NOT A DEPOSIT • NOT FDIC INSURED • NO BANK GUARANTEE • MAY LOSE VALUE
Vanguard Personal Advisor
Stocks, Options, Mutual funds, ETFs
N/A
$20 per year
N/A
Financial advice powered by relationships, not commissions.
TradeStation
Stocks, Bonds, Options, Mutual funds, ETFs, Cryptocurrency
$0 + $0.50/contract
$0 per month
$50
Deposit qualifying assets of $5,000+
A platform built for all kinds of traders and all styles of trading
Sofi Invest
Stocks, ETFs, Cryptocurrency
N/A
0%
Get one free stock worth up to $1,000
Open an account
A free way to invest in stocks, ETFs and crypto.
Moomoo
Stocks
$0
$0 per year
Get a free stock valued up to $350
Open your Futu brokerage account via Moomoo
Trade stocks on the US, Hong Kong, Shanghai and Shenzhen markets.
loading

Compare up to 4 providers

*Signup bonus information updated weekly.

The value of any investment can go up or down depending on news, trends and market conditions. We are not investment advisers, so do your own due diligence to understand the risks before you invest.

Is it a good time to buy CytoDyn stock?

The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.

This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.

CytoDyn price performance over time

Historical closes compared with the close of $1.34 from 2021-10-21

1 week (2021-10-15) -5.63%
1 month (2021-09-22) -45.53%
3 months (2021-07-22) -25.56%
6 months (2021-04-22) -59.15%
1 year (2020-10-22) -50.00%
2 years (2019-10-22) 325.40%
3 years (2018-10-22) 157.69%
5 years (2016-10-21) 103.03%

CytoDyn financials

Revenue TTM $41,000
Gross profit TTM $0
Return on assets TTM -57.11%
Return on equity TTM 0%
Profit margin 0%
Book value $0.01
Market capitalisation $937.5 million

TTM: trailing 12 months

CytoDyn share dividends

We're not expecting CytoDyn to pay a dividend over the next 12 months.

CytoDyn share price volatility

Over the last 12 months, CytoDyn's shares have ranged in value from as little as $1.25 up to $7.4. A popular way to gauge a stock's volatility is its "beta".

Beta is a measure of a share's volatility in relation to the market. The market (OTCQB average) beta is 1, while CytoDyn's is -0.8159. This would suggest that CytoDyn's shares have been inversely-correlated to the average (for this exchange) – so when the broader market trended up or down, CytoDyn has bucked the trend.

CytoDyn overview

CytoDyn Inc. operates as a late-stage biotechnology company. The company focuses on developing treatments for multiple therapeutic indications based on leronlimab, a novel humanized monoclonal antibody targeting the CCR5 receptor. Its Leronlimab is in a class of therapeutic monoclonal antibodies designed to address unmet medical needs in the areas of human immunodeficiency virus (HIV), cancer, immunology, and novel coronavirus disease (COVID-19). The company has completed a Phase 2b pivotal trial using leronlimab in combination with antiretroviral therapies in HIV-infected treatment-experienced patients, as well as completed a Phase 2b/3 investigative trial with leronlimab as a once-weekly monotherapy for HIV-infected patients. It is also conducting a Phase 1b/2 clinical trial with leronlimab in metastatic triple-negative breast cancer. The company was formerly known as RexRay Corporation.

Frequently asked questions

What percentage of CytoDyn is owned by insiders or institutions?
Currently 10.54% of CytoDyn shares are held by insiders and 0.131% by institutions.
How many people work for CytoDyn?
Latest data suggests 24 work at CytoDyn.
When does the fiscal year end for CytoDyn?
CytoDyn's fiscal year ends in May.
Where is CytoDyn based?
CytoDyn's address is: 1111 Main Street, Vancouver, WA, United States, 98660
What is CytoDyn's ISIN number?
CytoDyn's international securities identification number is: US23283M1018
What is CytoDyn's CUSIP number?
CytoDyn's Committee on Uniform Securities Identification Procedures number is: 23283M101

More guides on Finder

Ask an Expert

You are about to post a question on finder.com:

  • Do not enter personal information (eg. surname, phone number, bank details) as your question will be made public
  • finder.com is a financial comparison and information service, not a bank or product provider
  • We cannot provide you with personal advice or recommendations
  • Your answer might already be waiting – check previous questions below to see if yours has already been asked

Finder.com provides guides and information on a range of products and services. Because our content is not financial advice, we suggest talking with a professional before you make any decision.

By submitting your comment or question, you agree to our Privacy and Cookies Policy and finder.com Terms of Use.

Questions and responses on finder.com are not provided, paid for or otherwise endorsed by any bank or brand. These banks and brands are not responsible for ensuring that comments are answered or accurate.
Go to site